chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Headache; Sore muscles; Sore joints; Nausea; Intense pain at injection site; Redness at injection site; Swelling at injection site; Patchiness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on 14Apr2021 at 19:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, shellfish allergy and egg allergy(raw egg). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included salbutamol (ALBUTEROL), budesonide, formoterol fumarate (SYMBICORT), Montelukast sodium (SINGULAR) and levocetirizine dihydrochloride (XYZAL); all taken from unknown dates for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER2613) via an unspecified route of administration on 24Mar2021 at 08:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 11:00 the patient experienced fever, headache, sore muscles, sore joints, nausea, intense pain at injection site, redness and swelling, and patchiness at injection site. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, headache, sore muscles, sore joints, nausea, intense pain at injection site, redness and swelling, and patchiness at injection site were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Have headaches / 6 months later and still have them; Hot flashes / 6 months later and still have them; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles shot with an associated reaction of no adverse event (received 1st dose on an unknown date, 2 months ago from the 2nd dose).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than 6 months after receiving Shingles vaccine, the patient experienced headache and hot flashes. On an unknown date, the outcome of the headache and hot flashes were not recovered/not resolved.   It was unknown if the reporter considered the headache and hot flashes to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The age group was not reported but selected as an adult as per the vaccine indication. The patient received 2nd Shingles shot and had headache and hot flashes. The reporter stated that 6 months later, he or she still had the events.
Wife had high fever of 100.7; fatigue; chills; This is a spontaneous report from a contactable consumer or other non hcp (patient's husband). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient received first dose and had high fever of 100.7- fatigue and chills after a week on an unspecified date. The reporter was concerned about her getting the vaccine was it normal to have side effects after the first dose. The patient underwent lab tests and procedures which included body temperature with 100.7. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Shortness of breath, chest pain, nausea, vomiting, dizziness Treatment: Scopolamine patch, zofran discharged back to skilled nursing facility
Large red lump at the injection site; Little itchy in the area the vaccine was administered; Chills; Felt very tired; A spontaneous report was received from a consumer concerning a 71 years old female patient who had received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some chills, felt very tired/fatigue and had a little itchy in the area the vaccine was administered/ injection site pruritus, large red lump at the injection site/injection site mass.  The patient's medical history as reported by the reporter included, the patient was allergic to aspirin and had high cholesterol. Concomitant medications used by the patient were citalopram, carbamazepine, and vitamins.   On 18 Jan 2021, prior to the onset of the events, the patient had received first of their two planned doses of mRNA-1273 (Lot number: 013-204) through unknown route on left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, patient experienced some chills, felt very tired and had a little itchy in the area the where the vaccine was administered. On 26 Jan 2021, the patient woke up with a large red lump at the injection site and it was very very itchy. The itchiness was driving her nuts and patient consulted her pharmacist about delayed reactions to the vaccine, and pharmacist prescribed Benadryl, a Hydrocortisone cream and ice patchs, and had encouraged her to report this symptoms. On an unknown date, on the day of reporting the injection site became lighter and softer, not the big, round, hard red lump that she had a few days ago.  Treatment activities were done with diphenhydramine, hydrocortisone cream, ice patch.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, experienced some chills, felt very tired, and had a little itchy in the area the vaccine was administered, large red lump at the injection site   were unknown.
I received a dose of shingrix 50 MCG INJ (IM) sngdse vl10pk administered .5 ML in the muscle of left arm. My arm is red swollen and hot at the point of injection.
13:42 (7 minutes after vaccination) - developed lightheaded, BP75/26, HR 90, patient laid self to the floor 13:44 - BP 94/43, HR 48 - continue laid down 13: 48 - BP 111/60, HR 58 13:50 - 128/67, HR 81
Patient fainted shortly after getting vaccine. His wife and I helped support him on the chair so that he did not fall. We performed supportive measures - drink of water, cold compress.
I started getting symptoms of scratchy throat that I thought was allergies. Then the next day I still had a scratchy throat. I took an at home COVID-19 test that was negative. I then developed a cough and could not stop coughing. That night I got a fever and was achy. I took another COVID-19 test that was positive. I still had fever, cough, and aches. I did lose my voice some as well. I called my doctor but haven't had a call back yet.
Tingling around mouth 9/9 @ 10:13; C/o dizziness; 10:20 BP 152/100 Pulse 120; 10:40 BP 132/94.   Pulse 94; Urgent Care visit 9/12/21; Advised to complete VEARS 1300: BP 136/86 Pulse 123 R 16 T 98.3; Prescribed Meclizine for dizziness; Excuse from work note
Ultra Sound found a massive blood clot from my right foot extending to my upper right hip area.  Swollen right foot, right leg warm and red.
Information has been received from a healthcare worker referring to unspecified number of patients (age and gender were not reported). On unspecified dates the patients were vaccinated with improperly stored doses of GARDASIL lot # K023432, expiration date 18-JUN-2016, (dose, dose #, route and application site were not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Initial pain when flu vaccine was given, chills that night. Swelling to elbow of left arm next day and continued down arm to fingers by third day. Private MD was called suggested cold-hot applications. Swelling started to subside next day.
Received 3 Shingrix; This case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on June 2021) and Shingrix (2nd dose received on September 2021).   In November 2022, the patient received the 3rd dose of Shingrix. In November 2022, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 30-NOV-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient reported that he/she received three doses of Shingrix vaccine. The patient wanted to know if this hurt him/her. Additional supportive information: The patient received extra dose of Shingrix in error, which led to extra dose administered. Follow-up would not possible as no contact details were available.
Multi-embolic stroke of the posterior circulation. Symptoms including tinnitus, headache, and left upper quadrant visual field deficit developed on 1/26/2022. Presented to Hospital on 1/27/2022, was admitted and found to have multi-embolic posterior circulation stroke.
The day after the injection, minor sore arm.  Severe chills, vomiting.  These were present for approximately 24 hours.  Continuing fatigue.
Pt was given Kinrix in error at 4 months of age. No adverse effect noted at this time.
Pt vaccinated with Influenza developed headache, felt nauseated,temp rose to 101 oral. "Felt very sick."
Blood immunoglobulin M increased Information has been received from a physician concerning a female patient in her 70's who was vaccinated with a dose of hepatitis A virus vaccine inactivated (date unspecified). Subsequently, the patient experienced elevated IGM antibody. Unspecified medical attention was sought. The physician reported that that was the only clinical factor for hepatitis that was evident. The patient's present status was reported as not recovered. No product quality complaint was involved.  Additional information has been requested.
A 35-year-old female patient with a history of fibroids, had received a dose of TYPHIM VI (route, site and lot number not reported) on 06 April 2007 and on the day of vaccination, she "got sick" leading to an emergency room visit on 08 April 2007. The patient had a pregnancy test performed on 04 April 2007 prior to immunization and the results were unknown at the time of vaccination (results not reported). While at the emergency room on 08 April 2007, the patient had another pregnancy test performed and the results were positive. The patient subsequently had a miscarriage on 08 May 2007. According to the patient, "while in the military she had a pregnancy test on 04 April 2007, was forced to take TYPHIM VI vaccine before test result was received". Concomitant medications included prenatal vitamins and no other vaccines had been received during the four weeks prior to receipt of TYPHIM VI. The patient had known allergies to Doxycycline, "Cipalopram", Oxycodone and two other antibiotics (names not provided). She had no prior pregnancies and her expected date of confinement had been December 2007; the date of her last menstrual period was unknown. At the time of the report, it was unknown if any prenatal testing had been performed. The patient recovered from the event and no additional information was provided.
Burning; Allergic reaction; Hives all over her body; Face swelled up; Lips welled up; Throat swelled up; A spontaneous report, was received from a consumer (patient's daughter), concerning a 78 years-old female patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced allergic reaction (hypersensitivity), hives all over her body (urticaria), face swelled up (swelling face), lips swelled up (lip swelling), throat was swelled up (pharyngeal swelling), and burning (burning sensation).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 04-Feb-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown), intramuscularly for the prophylaxis of COVID-19 infection.  On 06-Feb-2021, approximately 48 hours after vaccination, the patient developed allergic reaction and had hives all over her body. The patient received diphenhydramine for hives. The patient also stated that inside of her was burning, face swelled up, lips swelled up and throat swelled up. The patient rushed to emergency room (ER). They needed to take the patient to an allergist because they wanted to find out if this was related to the vaccine. The allergist told her that they couldn't do an allergy testing. The patient asked if there were any reports on people showing allergic reaction 48 hours later after the vaccine. The patient was scheduled to get the second dose.  Action taken with second dose of mRNA-1273 in response to the events was not reported.   The outcome of events, allergic reaction, hives all over her body, face swelled up, lips swelled up, throat was swelled up, and burning, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
thirsty; feels very dehydrated; dry lips and mouth; dry lips and mouth; This spontaneous case was reported by a consumer and describes the occurrence of   in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021 at 9:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.    Reporter did not allow further contact
Fever 100.5; chills; aches; very mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 11:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Allergic history to medications, food, or other products was not reported. The concomitant medications included cyanocobalamin (B12), pyridoxine hydrochloride (VITAMIN B-6), tocopherol (VITAMIN E), ascorbic acid (VITAMIN C), phytomenadione (VITAMIN K), iron (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) on unknown date for unspecified indication. The patient previously received first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 10:00, the patient experienced fever 100.5 (unspecified units), chills, aches, very mild headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever 100.5, chills, aches, very mild headache was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07May2022 at 12:00 as dose 4 (booster), single (Lot number: FM9992) at the age of 42 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 22Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Jun2022) Positive, notes: Positive antigen home test including congestion body aches fatigue; (22Jun2022) positive, notes: Initial positive test; (28Jun2022) Negative, notes: negative PCR. Therapeutic measures were taken as a result of drug ineffective, covid-19.
9/28/17 The 2nd rabies vaccine was given in the left arm, the reaction gave me a very bad migraine, fever, joint swelling, body aches, dizziness, and weakness. 9/29/17 6:60am I went to the ER and was seen, given MOTRIN and monitored for fever and joint swelling to resolve. I went home and slept, took that whole day off work. By 9/30/17 I was feeling better.
Pain under arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain under arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2022 at 7:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain under arm). At the time of the report, PAIN IN EXTREMITY (Pain under arm) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient was currently having pain under arm was on the side of the vaccination received. Patient reported as she knows lymph nodes was there and was reported before. The caller had no other symptoms to report.  Concomitant medication information was not reported Treatment information was not reported
"Received shot around 4 pm. Between 6-630 pm, my throat was closing up, I had chills, nausea, my heart was racing and I was light-headed. I took BENADRYL and a half-hour later, I felt better."
On the of evening of 12/23/2022, my nose began running. On 12/24/2022, I had some sinus congestion and a runny nose. It began to feel like a mild cold. On 12/25/2022, I felt flu-ish, so I took a home antigen test and got a positive result. By the end of the day, I had a severe headache, body aches, nasal congestion, runny nose, and a fever of over 101. Over the next three to four days, I had the same symptoms, but stronger. The fever was intermittent, and I was very fatigued and slept a lot. This went on for about a week. It felt as if the illness were moving downward in my body. For example, I developed a sore throat. Afterwards, I developed tightness in the chest. On 12/26/2022 or 12/27/2022, I began taking PAXLOVID. Within a day or two, I felt a lot better. I was tired for several weeks and continued to test positive for two to three weeks. However, the PAXLOVID made the symptoms improve after a couple of days. The main symptom that lingered was the fatigue.
Day of vaccine (evening) arm soreness at injection site, swollen lymph node in armpit of injected arm Day after vaccine (upon waking 4/9/21), arm very sore, round red patch of skin/inflammation at injection site, swollen painful lymph node in armpit of injected arm Day after vaccine (around 11:00 a.m.), started feeling very fatigued, body achy, tingly skin, cold chills so rested the remainder of the day. Felt better the next day (4/10/21).
3/30/2021: Whole Body; Acute Myalgia,  Acute Arthralgia,  Acute Allodynia. Resting Tachycardia >3 hrs, fever between 101-103.  Symptoms began approx. 12:00pm and began to subside when awoke the following morning at 9:00 am  3/31/2021:   Full left arm paresthesia. Symptom began approx. 9:00 am when awoke.
Hives developed about 2 weeks after 1st vaccination and have continued daily for over 1+ years now.  Have been on 12 weeks of Allegra 2X day, 1 singulaire and 2 Zyrtec 50 mg 2X day.  Hives still appear but with less itch.  Tried stopping treatment but then return  within  hours with insane itching to the point of tearing skin. Hives are mainly on forearms and hands, but also appear on knees and legs, chest and shoulders and sometimes upper torso and abdomen.  Hives also appear with pressure applied areas, like under watch area or near a seam from clothing indenting the skin.  Have also in this time period developed a distaste and smell for eggs. As of this past weekend 4/16/23 hives are seeming to surface more and afraid more or different treatment may be needed.
Deceased 12/16/2021; Hospitalized 12/15/2021; COVID-19 positive 12/15/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 12/15 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Severe sepsis (HCC) [A41.9, R65.20] Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is an 86 year old male with past medical history significant for non-hodkin's lymphoma, CAD, CABG in 1992, COPD, DMT2 who presented to the ED 12/15 with altered mental status and SOB. He was in respiratory distress upon arrival to ED and was intubated. Found to be COVID positive. He developed septic shock requiring Epi, NE, and vasopressin. Blood cultures positive for GPCs in pairs and chains. Strep pneumo urine antigen negative. UA positive for blood, bacteria, leukocytes. He was started on broad spectrum antibiotics. Labs were notable for AKI, elevated troponin, leukocytosis, thrombocytopenia. On 12/16am, patient developed pulseless VT. ROSC after ~7 minutes. US 12/16 showing right peroneal vein DVT.    GOC discussion with family 12/16: All family in agreement that patient would never be happy with a quality of life where he was dependent on machines or others to help hi live. He would never want to be confined to a nursing home. If he could not go back to the quality of life he had before admission, he would not want to continue care. Given heart failure/cardiac arrest, circulatory shock, acute renal failure, bacteremia, underlying lymphoma that cannot be treated at present time, and COVID requiring a ventilator, family is requesting DNR with plans to transition to comfort care this afternoon after daughter arrives. All family in agreement. Dr. present for length of goals of care discussion (see separate note) and in agreement with plan.  On follow up, all children and spouse present and in agreement to withdraw care. Patient has one brother who family has been keeping updated and in agreement with whatever patient's spouse and children decide. Family tearful but appropriate. Dr. updated.   I was called by nurse for signs of death. On exam, no heart or lung sounds auscultated for 2 minutes. No palpable pulse for two minutes. No discernible chest rise or fall. No spontaneous movements. Pupils fixed and dilated. No response to noxious stimuli. Time of death 1615. Dr. updated.